Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection. - Singh B; Sharan R; Ravichandran G; Escobedo R; Shivanna V; Dick EJ Jr; Hall-Ursone S; Arora G; Alvarez X; Singh DK; Kaushal D; Mehra S (JCI insight, 2024)